Entourage Health Corp. (ENTG.V)
| Previous Close | 0.0550 |
| Open | 0.0550 |
| Bid | 0.0500 x N/A |
| Ask | 0.0550 x N/A |
| Day's Range | 0.0500 - 0.0550 |
| 52 Week Range | 0.0350 - 0.3100 |
| Volume | |
| Avg. Volume | 117,326 |
| Market Cap | 15.199M |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2970 |
| Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.05 |
- GlobeNewswire
Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures
TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central and Eastern Canada (“LPF”), adding an additional $8.9 million in non-dilutive funding availability (the “Credit Facility Amendments”). Net pro
- GlobeNewswire
Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures
TORONTO, June 21, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to provide an update on the previously announced proposed amendments (the “Proposed Amendments”) to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the Company governing the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the
- GlobeNewswire
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures
Company confirms it is one of many positive steps being taken to improve debt position and streamline capital structure for long-term successTORONTO, June 20, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that holders (the “Debentureholders”) of the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the “Debentu
